View Scopus Profile

William J Muller

Associate Professor, Pediatrics

https://orcid.org/0000-0001-7690-0695

Phone+1 312 227 8282
Emailwjmuller@northwestern.edu

Source: Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

29 Active
41 Finished

1 - 25 out of 70 results

Active

Gilead GS-US-540-5823: A Phase 2/3 Single-Arm, Open-Label Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Remdesivir (GS-5734?) in Participants from Birth to < 18 Years of Age with COVID-19
Muller, W. J.
Gilead Sciences, Inc.
7/15/20 → 8/31/50
Project: Research project
NAB-BC-3781-1202: A Phase 1, Open-Label, Two-Part Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Intravenous Lefamulin in Hospitalized Pediatric Subjects Receiving Standard of Care Antibiotic Therapy for Confirmed or
Muller, W. J.
Nabriva Therapeutics Ireland DAC
6/11/20 → 8/31/50
Project: Research project
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Muller, W. J.
Duke University, National Institute of Allergy and Infectious Diseases
5/5/20 → 5/31/23
Project: Research project
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children per Standard of Care
Muller, W. J.
Duke University, National Institute of Child Health and Human Development
4/24/20 → 9/13/22
Project: Research project
Clinical Comparison of the BD FecalSwab Collection, Transport and Preservation System to the Cary-Blair Specimen or the Unpreserved Specimen on the BD MAX Enteric Assays
Muller, W. J.
Becton, Dickinson and Company
2/25/20 → 8/31/50
Project: Research project
A Phase 2, Open-Label, Non-Comparative Clinical Trial to Study the Safety and Efficacy of Posaconazole (POS, MK-5592) in Pediatric Participants Aged 2 to <18 Years With Invasive Aspergillosis
Muller, W. J.
Merck Sharp & Dohme Corp
2/3/20 → 8/31/50
Project: Research project
Consultation of Influenza Trial Design for Immuno-Compromised Pediatric Subjects
Muller, W. J.
Seqirus Inc.
11/22/19 → 8/31/50
Project: Research project
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)
Muller, W. J.
MedImmune, Inc.
10/25/19 → 8/31/50
Project: Research project
A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children (MEDLEY)
Muller, W. J.
MedImmune, Inc.
10/25/19 → 8/31/50
Project: Research project
DAS181-3-01: A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS 181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
Muller, W. J.
Ansun Biopharma, Inc.
6/20/19 → 8/31/50
Project: Research project
A Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability, Efficacy and Pharmacokinetics of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Subject
Muller, W. J.
Astellas Pharma US. Inc.
3/19/19 → 8/31/50
Project: Research project
Protocol 63623872FLZ3002; Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and El
Muller, W. J.
Janssen Research & Development, LLC
3/18/19 → 8/31/50
Project: Research project
CP40559: A MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY TO ASSESS THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF BALOXAVIR MARBOXIL IN OTHERWISE HEALTHYPEDIATRIC PATIENTS FROM BIRTH TO 1 YEAR WITH INFLUENZA-LIKE SYMPTOMS
Muller, W. J.
Genentech, Inc.
3/11/19 → 8/31/50
Project: Research project
A Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Relationships of Different Doses of JNJ-53718678 in Children ?28 Days
Muller, W. J.
Janssen Research & Development, LLC
2/22/19 → 8/31/50
Project: Research project
Protocol# 1832301: Collection of Dual Throat Swabs for the detection of Group A Streptococcus (MSA Laboratory - SOW)
Muller, W. J.
Alere Scarborough, Inc., Abbott Laboratories
1/25/19 → 12/31/50
Project: Research project
Protocol# 1832301: Collection of Dual Throat Swabs for the detection of Group A Streptococcus (PPR, CTA SOW 9)
Muller, W. J.
Abbott Laboratories
1/25/19 → 12/31/50
Project: Research project
MK1986-014-1022: A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Oral and IV TedizolidPhosphate (MK-1986) in Inpatients Under 2 Years Old
Muller, W. J.
Merck Sharp & Dohme Corp
11/20/18 → 8/31/50
Project: Research project
Alere 1822001: Evaluation of the Clinical Performance of the Modified AlereTM Influenza A & B Test
Muller, W. J.
Alere Scarborough, Inc.
11/20/18 → 8/31/50
Project: Research project
TP-434-028: A PHASE 1, OPEN-LABEL, MULTICENTER STUDY TO DETERMINE THE PHARMACOKINETICS AND SAFETY OF INTRAVENOUS ERAVACYCLINE IN CHILDREN WITH SUSPECTED OR CONFIRMED BACTERIAL INFECTION
Muller, W. J.
Tetraphase Pharmaceuticals, Inc.
10/31/18 → 10/30/50
Project: Research project
MK-7625A-034: Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Versus Meropenem in Pediatric Subjects with Complic
Muller, W. J.
Merck Sharp & Dohme Corp
10/11/18 → 8/31/50
Project: Research project
MK-1986-018 - A Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Subjects from Birth to <12 Years of Age with Acute Bacterial
Muller, W. J.
Merck Sharp & Dohme Corp
8/1/18 → 8/31/50
Project: Research project
REMPEX-507 Tango Kids: An Open label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of a Single Dose Infusion of VABOMERE (Meropenem-Vaborbactam) in Pediatric Subjects from Birth to Less Than 18 Years of Age with....
Muller, W. J.
Rempex Pharmaceuticals, Inc.
7/9/18 → 7/8/21
Project: Research project
Protocol 1803201 - Evaluation of the Alere Influenza A & B Test, (PPR CTA SOW 7)
Muller, W. J.
Alere Scarborough, Inc.
2/4/18 → 2/2/23
Project: Research project
Protocol ISN: 9766-MA-3034 - Observational Disease Registry of Patients Treated with Systemic Mold-Active Triazoles
Muller, W. J.
Astellas Pharma US. Inc.
12/31/17 → 8/31/50
Project: Research project
SOW 6 Protocol 1729601 - Nasopharyngeal and Mid-Turbinate Swab Specimen Collection for Use in Development of Rapid Diagnostic Tests for Respiratory Syncytial Virus (RSV)
Muller, W. J.
Alere Scarborough, Inc.
12/1/17 → 11/30/22
Project: Research project